Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
Sign Up to like & getrecommendations! Published in 2017 at "NPJ Vaccines"
DOI: 10.1038/s41541-017-0032-6
Abstract: AbstractmRNA represents a promising new vaccine technology platform with high flexibility in regard to development and production. Here, we demonstrate that vaccines based on sequence optimized, chemically unmodified mRNA formulated in optimized lipid nanoparticles (LNPs)… read more here.
Keywords: immune; prophylactic vaccines; vaccine technology; technology ... See more keywords